CLASS II Drug recall · Reported 30 Sep 2015 · FDA Enforcement Report

0.9% Sodium Chloride Injection recalled by Baxter Healthcare

Baxter Healthcare is recalling 0.9% Sodium Chloride Injection, USP Mini-bag Viaflex Container, Single Dose Container, distributed nationwide in the US. The recall was initiated on 2 Sep 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: P329821, Exp 08/31/2016
NDC0338-0043, 0338-0049
Quantity recalled139,104 Bags

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1816-2015
FDA event ID
72060
Recalling firm
Baxter Healthcare, Jayuya, PR
Manufacturer
Baxter Healthcare Corporation
Classification
Class II
Status
Terminated
Recall initiated
2 Sep 2015
FDA classified
18 Sep 2015
Reported
30 Sep 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Mold

Timeline

2 Sep 2015Recall initiated by company
18 Sep 2015Classified by FDA+16 days
30 Sep 2015Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility: Recalling firm reported a complaint for mold on the interior surface of the overpouch.

Product as listed by the FDA

0.9% Sodium Chloride Injection, USP, 100 mL MINI-BAG VIAFLEX Container, Single Dose Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38

Where it was distributed

Nationwide and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility: Recalling firm reported a complaint for mold on the interior surface of the overpouch.

Which lots are affected?

Lot #: P329821, Exp 08/31/2016

Where was it sold?

Nationwide and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Baxter Healthcare

All 572

Other Sodium Chloride recalls

All 132